Can-Fite BioPharma Ltd.
CANFAMEXHealthcare● Active
$3.08
$-0.01(-0.32%)
Market Cap$1657040
P/E Ratio—
52W High$23.4
52W Low$2.83
Can-Fite BioPharma Ltd.（CANF）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CANF · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.41M | $0.67M | $0.74M | $0.81M | $0.85M |
| Cost of Revenue | $0.02M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $0.38M | $0.67M | $0.74M | $0.81M | $0.85M |
| Gross Margin %(computed) | 94.07% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Expenses | |||||
| R&D Expenses | $6.75M | $5.76M | $5.98M | $7.76M | $9.85M |
| G&A Expenses | $0.00M | $3.05M | $2.96M | $3.14M | $3.85M |
| Total Operating Expenses | $10.41M | $8.80M | $8.94M | $10.91M | $13.70M |
| Operating Income | ($10.03M) | ($8.13M) | ($8.20M) | ($10.10M) | ($12.84M) |
| Operating Margin %(computed) | — | — | — | — | — |
| Interest Income | $0.29M | $0.29M | $0.51M | $0.22M | $0.02M |
| Interest Expense | $0.01M | $0.01M | $0.01M | $0.08M | $0.02M |
| Income Before Tax | ($9.91M) | ($7.88M) | ($7.63M) | ($10.17M) | ($12.62M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.36M | ($0.02M) |
| Net Income | ($9.91M) | ($7.88M) | ($7.63M) | ($10.17M) | ($12.60M) |
| Net Margin %(computed) | — | — | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-12.03 | $-1.08 | $-1.80 | $-3.75 | $-9.00 |
| Wtd Avg Shares | 0.82M | 7.25M | 4.26M | 2.72M | 1.53M |
| EBITDA | ($10.00M) | ($8.12M) | ($8.18M) | ($10.08M) | ($12.83M) |
| EBITDA Margin %(computed) | — | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · M
深入了解Can-Fite BioPharma Ltd.
关于Can-Fite BioPharma Ltd.（CANF）损益表
Can-Fite BioPharma Ltd.（CANF）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，CANF实现营收$0.00B，毛利润$0.00B（毛利率94.07%），净利润($0.01B)（净利率-2426.67%）。
常见问题
CANF · 4 问Can-Fite BioPharma Ltd.（CANF）2025财年营收为$0.00B，同比down39.4%。
CANF revenueCANF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08